Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR8005Referred to Committee

Stop Pills That Kill Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-03-19
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

Gabe Evans
Gabe Evans
Republican · CO · Representative
Votes with party: 96.8% (554 recorded votes)

Full profile: /officials/E000300

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2026-03-19

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2026-03-19
  • House Committee on the JudiciaryReferred To · 2026-03-19

Previously

  • Energy and Commerce CommitteeReferred To · 2026-03-19
  • Judiciary CommitteeReferred To · 2026-03-19

Plain-English Summary

This bill aims to address the opioid crisis and drug-related deaths by targeting the production, distribution, and sale of dangerous pills, likely through stricter penalties for drug traffickers and manufacturers who knowingly produce or sell counterfeit or contaminated medications. The legislation would affect law enforcement agencies, pharmaceutical companies, and potentially individuals involved in illegal drug operations. The bill has been referred to committees that handle criminal justice and drug regulation to determine which parts fall under their respective areas of responsibility.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Crime and Law Enforcement

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8005 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8005 To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 19, 2026 Mr. Evans of Colorado introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Stop Pills That Kill Act''. SEC. 2. DEFINITION. In this Act, the term ``counterfeit fentanyl or methamphetamine substance'' means a substance that-- (1) contains fentanyl, any analogue of fentanyl, or methamphetamine; and (2) is marketed under, sold under, or falsely bears the trademark, trade name, or other identifying mark, imprint, number, or any likeness thereof of another product. SEC. 3. PROHIBITED ACTS. Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 843(d)(2)) is amended, in the matter preceding subparagraph (A), by inserting ``, fentanyl, an analogue of fentanyl, or a counterfeit substance'' after ``methamphetamine''. SEC. 4. COMPREHENSIVE PLAN. Not later than 180 days after the date of enactment of this Act, the Administrator of the Drug Enforcement Administration shall establish and implement an operation and response plan to address counterfeit fentanyl or methamphetamine substances that includes-- (1) strategies to enable and empower Federal law enforcement efforts to investigate and seize counterfeit fentanyl or methamphetamine substances; (2) specific ways that education and prevention efforts to stop the use of counterfeit fentanyl or methamphetamine substances will be increased, including how-- (A) ongoing efforts, such as Operation Engage, are effective in increasing education and prevention; and (B) how the efforts described in subparagraph (A) are tailored to youth and teen access; and (3) an audit of current campaigns, including the ``One Pill Can Kill'' campaign, on counterfeit fentanyl or methamphetamine substances, including a review of data and other available information on how the campaigns can be tailored, adjusted, or improved to better address the flow of counterfeit fentanyl or methamphetamine substances. SEC. 5. REPORT TO CONGRESS. (a) Report.--Not later than 1 year after the date of enactment of this Act, and every year thereafter, the Attorney General, in consultation with the Administrator of the Drug Enforcement Administration and Director of the Office of National Drug Control Policy, shall submit to Congress a report on information regarding the collection and prosecutions of counterfeit fentanyl or methamphetamine substances. (b) Contents.--The report required under subsection (a) shall include the following: (1) Data on the aggregate number of counterfeit fentanyl or methamphetamine substances seized and collected by Federal law enforcement agencies. (2) A breakdown on how many counterfeit fentanyl or methamphetamine substances are in pill form. (3) A breakdown on which illicit substances are present in the counterfeit fentanyl or methamphetamine substances that are in pill form. (4) Data outlining where and when counterfeit fentanyl or methamphetamine substances were seized. (5) Data on the charges filed pursuant to paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)) in relation to a counterfeit fentanyl or methamphetamine…
Show the remaining 113 wordsHide the remaining 113 words
substance, particularly in pill form, unless disclosure of the data would-- (A) require unsealing an indictment; or (B) undermine investigations and charges brought by the Department of Justice. (6) Data on the convictions and sentences against those who are found guilty under paragraph (1) or (2) of section 401(a) of the Controlled Substances Act (21 U.S.C. 841(a)) as it pertains to counterfeit fentanyl or methamphetamine substances, particularly those in pill form. (7) Any prevention measures that the Department of Justice, Drug Enforcement Administration, or Office of National Drug Control Policy are undertaking to limit and reduce the spread of counterfeit fentanyl or methamphetamine substances in pill form, including ongoing public awareness campaigns. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR7764National Threat Evaluation and Reporting Program Reassignment and Funding Reform Act of 2026
    Referred to Committee · 2026-05-14
  • HR7574ELO Realignment and Strategic Engagement Reform Act of 2026
    Referred to Committee · 2026-05-14
  • HR6387FIRE Act
    Passed House · 2026-04-27
  • HR1681Expediting Federal Broadband Deployment Reviews Act
    Passed House · 2026-04-21